To Med or Not to Med…That is the Question

According to the World Health Organization, depression is on the rise and is expected to be one of the biggest health problems we face by the year 2020. Millions of people take antidepressants every day; a significant number of them are women. We know that depression is far more common in women than in men and that the highest prevalence occurs during child bearing ages (mid-twenties to mid-forties). And, depression doesn’t disappear when a woman becomes pregnant. It is estimated that between 10% and 25% of pregnant women suffer with major depression.

So, while many commonly used antidepressants have been shown to be safe during pregnancy, countless numbers of women are plagued by the decision of whether to continue to take medication during their pregnancy, or stop. Nearly every woman is committed to do everything in her power to nurture and protect the baby growing in her womb. Frequently, those women who don’t or can’t have a serious mental illness, physical illness or addiction that interferes with their ability to care for themselves.

Far too often, women with depression or anxiety decide to discontinue their medications during pregnancy, and they base this decision on myth, fear, stigma and shame rather than scientific evidence of the actual risks and benefits of being on antidepressants during pregnancy.

It is important to remember that most women take these medications for a reason, often because depression has profoundly and quite negatively impacted their lives. Many women and healthcare practitioners fail to take into account the risks for a woman and her baby when stopping her antidepressant. Most healthcare providers are quick to relay the risks of staying on antidepressants, the biggest of which substantiated by the scientific literature, is neonatal withdrawal syndrome, which lasts two to three days after birth and is characterized by irritability and poor feeding. The scientific literature is largely mixed about other hazards of being on antidepressants while pregnant, but the largest study in 2013 showed no increased risk of malformations, miscarriage, stillbirth or pulmonary hypertension in the newborn.

What people spend far less time thinking about and talking about are the risks of untreated depression during pregnancy. Discontinuing antidepressants can have harmful consequences to the mother and her baby, which include:

  • increased use of cigarettes, alcohol or other substances
  • deteriorating social function, emotional withdrawal, worry related to pregnancy and excessive concern about their future ability to parent
  •  impaired ability to attend regular obstetric visits and comply with prenatal advice;
  • malnutrition which can lead to low birth weight
  • increase in risky behavior and impaired capacity to avoid dangerous behavior
  • heightened risk of self-injurious, psychotic, impulsive, and harmful behaviors
  • increased risk of postpartum depression or PPD
  • difficulty carrying out maternal duties and bonding with their children

Whether to continue taking any medication during pregnancy comes down to individual choice. But, far better it be an informed, evidence-based decision, than one based on societal pressure, shame or fear. The risks and benefits will depend on the person, her history of depression, severity of depression, length of time on and response to antidepressants, and whether or not non-pharmacologic therapies have been effective in treating her depression. Whatever you decide, it is important to remain connected to people who can help you, support you and recognize signs of depression interfering with your abundant life.

-Our Research Team-
Timothy D. Brewerton, MD, DLFAPA, FAED, DFAACAP, CEDS-S
Professor Emeritus of Psychiatry and Behavioral Sciences
Dr. Christopher Womack
Medical Director, Child and Adolescent Psychiatry

Dr. Christopher Womack joins SunCloud as our Medical Director, Child and Adolescent Psychiatry.

Dr. Womack is board certified in Adult as well as Child and Adolescent Psychiatry, attending the University of Chicago Pritzker School of Medicine. Adult psychiatry residency and child fellowship training were completed at the University of Chicago Medical Center.

Dr. Womack’s treatment  philosophy hinges on strength based, evidence informed care, where collaboration is central to guiding individualized treatment.  He has experience caring for children and teens from varied backgrounds, appreciating the importance of how identity can inform treatment.

Favorite pastimes are cooking new recipes and exploring Chicago’s rich cultural diversity through its neighborhood and fine dining experiences.

Elizabeth E. Sita, MD
Medical Director of Adult Services

Dr. Elizabeth E. Sita, MD, is a Board Certified psychiatrist specializing in the care of patients with eating disorders. She completed her undergraduate training at the University of Chicago and graduated with Highest Honors. She then earned her medical degree at Northwestern University Feinberg School of Medicine and was recognized with the Chairman’s Award for Excellence in Psychiatry. She subsequently completed residency with the Department of Psychiatry and Behavioral Sciences at McGaw Medical Center of Northwestern University, where she was elected Chief Resident and received the Resident Psychiatrist Leadership & Service Award.

Upon completing her training, Dr. Sita joined the staff atAscension Alexian Brothers Behavioral Health Hospital Hospital, where she served as Assistant Medical Director of the Center for Eating Disorders and Director of Transcranial Magnetic Stimulation Services before transitioning to lead the new inpatient eating disorder unit as Medical Director of Eating Disorder Services at Ascension Saint Joseph Hospital – Chicago. In these roles, she has cared for a multitude of adolescents and adults struggling with anorexia nervosa, bulimia nervosa, binge eating disorder, and other eating disorders as well as severe, cooccurring mood, trauma, personality, and substance use disorders.

Dr. Sita has been recognized throughout her training and practice for a commitment to excellence in patient care and for her ability to engage patients in their most challenging moments. Her passions include the care of treatment-resistant eating and mood disorders as well as questions of medical capacity and end-of-life decision making.

She believes that, first and foremost, human connection is key to mental health and well-being and strives to share this philosophy in each and every patient encounter. She is excited to bring her expertise to SunCloud Health as the Medical Director of Adult Services!

 

VIDEO: Meet Elizabeth E. Sita, MD, Medical Director of Adult Services

 

Lacey Lemke, PsyD
Assistant Vice President of Clinical Services

Dr. Lacey Lemke (she/her) is a licensed clinical health psychologist with specialized expertise in the treatment of eating disorders and the practice of medical and health psychology. She completed her doctoral training in clinical psychology with a Primary Care emphasis at the Adler School of Professional Psychology. Dr. Lemke went on to complete both her predoctoral clinical internship and postdoctoral fellowship through Ascension Health, where she gained advanced training working with individuals experiencing eating disorders and self-injurious behaviors, as well as within pediatric subspecialty settings including endocrinology, neurology, and adolescent medicine.

Dr. Lemke is deeply committed to providing evidence-based, compassionate care and collaborates closely with interdisciplinary teams to ensure comprehensive treatment. Her professional mission is to support patients in achieving their fullest potential by guiding them to the most appropriate level of care and empowering them to make meaningful, sustainable progress toward improved health and well-being.

VIDEO: 2. Meet Lacey Lemke, PsyD.